Effect of Adjuvant Imiquimod 5% Cream on Sustained Clearance of Anogenital Warts Following Laser Treatment

• Principais autores: U. B. Hoyme (Autor), M. Hagedorn (Autor), A.-E. Schindler (Autor), P. Schneede (Autor), W. Hopfenmüller (Autor), K. Schorn (Autor), A. Eul (Autor)
• Formato: Livro
• Publicado em: Hindawi Limited, 2001-01-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Objectives: Imiquimod is an immune response modifier that has demonstrated a good efficacy and relatively low recurrencerates in comparison to other genitalwart treatment modalities. The primary objective of this open-label study was to evaluate the effect on sustained clearance of treated lesions a...